Shareholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of stock options by exercise price range

Options Outstanding and Exercisable at March 31, 2020
Range of Exercise Prices	Number  Exercisable		Weighted  Remaining  Contractual  Life	Weighted  Average  Exercise  Price		Aggregate  Intrinsic Value (1)
$0.40 to $0.60		750,000	.5 years	$	0.64	$	—
$0.61 to $1.00		9,800,000	.4 years	$	0.67	$	—
$1.01 to $1.50		14,500,000	.5 years	$	1.25	$	—
$1.51 to $2.25		3,000,000	1.0 years	$	1.63	$	—
$0.40 to $2.25		28,050,000	.6 years	$	1.07	$	—

(1) The aggregate intrinsic value in the table represents the difference between the closing stock price on March 31, 2020 and December 31, 2019, and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on March 31, 2020 and December 31, 2019.

Schedule of stock warrants outstanding

	Number			Weighted  Average  Exercise  Price		Range  of  Exercise  Price		Weighted  Remaining  Contractual  Life (1)
Outstanding at December 31, 2018		4,865,640		$	0.77	$	0.20 – 1.23		1.5 years
Granted		—
Cancelled or expired		---
Exercised		—
Outstanding and exercisable at December 31, 2019		4,865,640			0.84		0.20 --1.23		1.5 years
Granted
Cancelled or expired		(100,000	)		0.20		0.20 – 0.20
Outstanding and exercisable at March 31, 2020		4,765,640		$	0.84	$	0.89 - 1.23		0.5 years

(1) The aggregate intrinsic value of the 4,765,640 and 4,865,640 outstanding and exercisable warrants at March 31, 2020 and December 31, 2019, respectively, was $0. The intrinsic value is the difference between the closing stock price on March 31, 2020 and December 31, 2019 and the exercise price, multiplied by the number of in-the-money warrants had all warrant holders exercised their warrants on March 31, 2020 and December 31, 2019.